It has been a pandemic since at least biblical times, and unless effective strategies harness the global tuberculosis scourge, the disease will remain problematic and pervasive — an unending plague throughout many regions of the world.
The Australian government said on Sunday it will earmark an additional A$1.2 billion ($859 million) in wage subsidies in the 2020/21 budget and that its frameworks assume that there will be a novel coronavirus vaccine next year.
A member of Tehran coronavirus committee said on Saturday that the procedure to produce COVID-19 vaccine has passed the stage of weak and animal trials, so that Tehran University scholars will initiate human trials for vaccines soon.
Political polarization and online misinformation are threatening vaccination programs worldwide, with public trust volatile and varying widely between countries, according to a global vaccine confidence study.
Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection in mice susceptible to the novel coronavirus. The investigators next plan to test the vaccine in nonhuman primates and humans to see if it is safe and effective in preventing COVID-19 infection. The study is available online in the journal Cell.
India is ready to mass produce COVID-19 vaccines when scientists give the go-ahead, Prime Minister Narendra Modi said in his Independence Day speech on Saturday, also launching a national project to roll out health identities for each citizen.